Replies to post #69611 on Biotech Values

[DewDiligence]

>So, the bottom line, at least for me, is to constantly re-evaluate your stocks. Would you still buy your current holdings today? That's something I try to constantly ask myself. If not, perhaps it's time to make a switch.<

I fully agree and I would even delete the word perhaps in your statement above. If a stock is not good enough to buy, it’s not good to hold.

[microcapfun]

>>When I buy a biotech, it's normally for a very specific reason and I will hold until certain specific events pass, whether that's an FDA decision on a drug, Phase II or III trial results, etc. If those events don't transpire the way I expect, the stock tanks, and therefore the story/outlook has changed, I have no problem selling and moving on at a loss.<<

You are leaving out one important reason to sell - even if a company is hitting all its targets, doing everything you hoped and more, racking up one success after another.

It may simply be overvalued.

Of course that's not so likely to be the situation these days ...

micro